Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Inflammatory eye disorders
•
Ophthalmology
•
Episcleritis
•
Uveitis and Ocular Immunology
•
Primary Care
What is your approach to evaluation and management of symptomatic nodular episcleritis?
Related Questions
How would you approach the management of dry corneal melt in a patient requiring high dose systemic steroids and no apparent underlying systemic autoimmune disease?
How do you approach the management of recurrent episcleritis in a patient with RA that is otherwise well-controlled?
When would you consider discontinuing immunosuppressive treatment in a quiescent uveitis patient without systemic manifestations of inflammation?
How often do you recommend ophthalmologic screening exams for patients with sarcoidosis?
Do you continue TNF inhibitors in patients with a new diagnosis of CLL?
Would you consider using a JAK inhibitor for a patient with RA associated scleritis?
How would you approach management of nodular scleritis in the setting of suspected GCA?
How do you approach a patient with idiopathic anterior uveitis who has ongoing disease despite adalimumab every two weeks?
Is it safe to continue azathioprine in a patient with severe bilateral panuveitis (thought to be related to sarcoidosis) and benign ethnic neutropenia, given worsening neutropenia since starting the medication, or should an alternative immunosuppressive agent be considered?
How do you treat idiopathic acute anterior uveitis that recurs immediately after a course of topical corticosteroids?
